The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
- 18 June 2008
- journal article
- Published by Elsevier in Brain Research
- Vol. 1215, 69-75
- https://doi.org/10.1016/j.brainres.2008.03.063
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Peripheral cannabinoids attenuate carcinoma-induced nociception in miceNeuroscience Letters, 2008
- Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptorsNature Neuroscience, 2007
- Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesiaEuropean Journal of Pharmacology, 2007
- Activation of peripheral cannabinoid CB1and CB2receptors suppresses the maintenance of inflammatory nociception: a comparative analysisBritish Journal of Pharmacology, 2007
- Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonistPAIN®, 2006
- The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?Supportive Care in Cancer, 2006
- Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic painNeuropharmacology, 2006
- Pain measurements and side effect profile of the novel cannabinoid ajulemic acidNeuropharmacology, 2005
- Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skinJournal of Dermatological Science, 2005
- Opioid responsivenessActa Anaesthesiologica Scandinavica, 1997